Validation of the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS) in the Russian Population.

Cognitive dysfunction Demyelinating diseases Multiple sclerosis Neuropsychological tests Psychological tests Validation study

Journal

Journal of the International Neuropsychological Society : JINS
ISSN: 1469-7661
Titre abrégé: J Int Neuropsychol Soc
Pays: England
ID NLM: 9503760

Informations de publication

Date de publication:
05 2022
Historique:
pubmed: 17 6 2021
medline: 14 5 2022
entrez: 16 6 2021
Statut: ppublish

Résumé

Cognitive dysfunction is common in multiple sclerosis (MS). The Brief International Cognitive Assessment for MS (BICAMS) battery of tests has been suggested as a measure for the evaluation of the cognitive status of MS patients. This study aims to validate the BICAMS battery in the Russian population of MS patients. Age- and sex-matched MS patients (n = 98) and healthy individuals (n = 86) were included in the study. Symbol Digit Modalities Test (SDMT), California Verbal Learning Test, 2nd edition (CVLT-II) and the Brief Visuospatial Memory Test - Revised (BVMT-R) were administered to all participants. The battery was readministered 1 month later to 44 MS patients to investigate the test-retest reliability. MS patients exhibited a significantly lower performance in testing with BICAMS than the control group in all three neuropsychological tests. Test-retest reliability was good for SDMT and CVLT-II (r = .82 and r = .85, respectively) and adequate for BVMT-R (r = .70). Based on the proposed criterion for impairment as z score below 1.5 SD the mean of the control group, we found that 34/98 (35%) of MS patients were found impaired at least in one cognitive domain. Patients with Expanded Disability Status Scale score ≥3.5 performed significantly worse than controls (SDMT, p < .0001; CVLT-II, p = .03; BVMT-R, p = .0004), while those with ≤3.0 scores did not. This study demonstrates that the BICAMS battery is a valid instrument to identify cognitive impairment in MS patients and it can be recommended for routine use in the Russian Federation.

Identifiants

pubmed: 34132190
pii: S1355617721000722
doi: 10.1017/S1355617721000722
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

503-510

Auteurs

Evgeniy Evdoshenko (E)

SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.

Kristina Laskova (K)

SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.

Maria Shumilina (M)

SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.

Ekaterina Nekrashevich (E)

SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.

Maria Andreeva (M)

SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.

Nikolay Neofidov (N)

SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.

Ivan Kalinin (I)

SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.

Daria Nikitchenko (D)

SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.

Anna Rogozina (A)

SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.

Alina Kupaeva (A)

SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.

Ilya Bulanov (I)

SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.

Christos Bakirtzis (C)

The Multiple Sclerosis Center, 2nd Department of Neurology, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Nicolaos Grigoriadis (N)

The Multiple Sclerosis Center, 2nd Department of Neurology, AHEPA University Hospital, Medical School, Aristotle University of Thessaloniki, Thessaloniki, Greece.

Natalia Khachanova (N)

Pirogov Russian National Research Medical University, Moscow, Russia.

Maria Davydovskaya (M)

Pirogov Russian National Research Medical University, Moscow, Russia.
State Budgetary Institution of Moscow City "Clinical Trials and Healthcare Technology Assessment Scientific Research Centre of Moscow Department of Healthcare", Moscow, Russia.

Gleb Makshakov (G)

SPb Center of Multiple Sclerosis and AID (SBIH City Clinical Hospital #31), St. Petersburg, Russia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH